These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20481263)

  • 21. Levetiracetam monotherapy for treatment of structural epilepsy in dogs: 19 cases (2010-2015).
    Kelly D; Raimondi F; Shihab N
    Vet Rec; 2017 Oct; 181(15):401. PubMed ID: 28847876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Successful treatment with levetiracetam in a case of Ohtahara syndrome caused by STXBP1 mutation].
    Yamashita S; Chiyonobu T; Yoshida M; Moroto M; Morita T; Morioka S; Kato M; Saitsu H; Morimoto M; Hosoi H
    No To Hattatsu; 2013 Jan; 45(1):64-6. PubMed ID: 23593750
    [No Abstract]   [Full Text] [Related]  

  • 23. Levetiracetam for the treatment of epilepsy among adults with intellectual disabilities.
    Deb S; Kaur Saini ST
    J Intellect Disabil Res; 2007 Jul; 51(Pt 7):564-5. PubMed ID: 17537170
    [No Abstract]   [Full Text] [Related]  

  • 24. Levetiracetam monotherapy for the treatment of infants with epilepsy.
    Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N
    Seizure; 2018 Mar; 56():73-77. PubMed ID: 29453114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinically relevant reduction of lamotrigine concentrations by carbamazepine.
    Koch HJ; Szecsey A; Vogel M
    Eur Psychiatry; 2003 Feb; 18(1):42. PubMed ID: 12648898
    [No Abstract]   [Full Text] [Related]  

  • 26. The clinical efficacy and safety of levetiracetam add-on therapy for child refractory epilepsy.
    Chen J; Liu XM; Yue X; Chen SZ
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2689-94. PubMed ID: 27383324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levetiracetam in clinical practice: efficacy and tolerability in epilepsy.
    Bilo L; de Leva MF; Meo R
    Can J Neurol Sci; 2010 May; 37(3):376-82. PubMed ID: 20481273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The value of levetiracetam in epileptic status].
    Pastor-Milán E; González-Torres V; Vilches R
    Rev Neurol; 2005 Oct 16-31; 41(8):508-9. PubMed ID: 16224741
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety profile of levetiracetam.
    Arroyo S; Crawford P
    Epileptic Disord; 2003 May; 5 Suppl 1():S57-63. PubMed ID: 12915343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The retrospective study of efficacy and safety of levetiracetam as an add-on treatment of epilepsy in children].
    Aĭvazian SO; Shiriaev IuS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):33-8. PubMed ID: 22500310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of levetiracetam for patients with supratentorial brain tumors.
    Yuan Y; Peizhi Z; Maling G; Wu L; Yunhe M; Xiang W; Qing M; Yanhui L; Ruofei L; Jiewen L
    J Clin Neurosci; 2015 Aug; 22(8):1227-31. PubMed ID: 26051171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levetiracetam: preliminary efficacy in generalized seizures.
    Kasteleijn-Nolst Trenité DG; Hirsch E
    Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levetiracetam in refractory pediatric epilepsy.
    Wheless JW; Ng YT
    J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics and indications of levetiracetam].
    Herranz JL; Argumosa A
    Rev Neurol; 2002 Sep; 35 Suppl 1():S110-6. PubMed ID: 12373663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
    Bailey KS; Dewey CW; Boothe DM; Barone G; Kortz GD
    J Am Vet Med Assoc; 2008 Mar; 232(6):867-72. PubMed ID: 18341442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Keppra in epilepsy treatment: efficacy and tolerability].
    Mukhin KIu; Pilin SV; Chadaev VA; Mironov MB; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):49-51. PubMed ID: 15704484
    [No Abstract]   [Full Text] [Related]  

  • 37. A prospective analysis of the outcome of levetiracetam in clinical practice.
    Nicolson A; Lewis SA; Smith DF
    Neurology; 2004 Aug; 63(3):568-70. PubMed ID: 15304598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacology and clinical results of levetiracetam (E Keppra(®) Tablets), a new antiepileptic drug].
    Ishii Y; Tanaka T
    Nihon Yakurigaku Zasshi; 2011 Feb; 137(2):95-102. PubMed ID: 21321459
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectiveness and tolerability of the new antiepileptic drugs: the position of levetiracetam].
    Arroyo S
    Rev Neurol; 2002 Aug 1-15; 35(3):227-30. PubMed ID: 12235583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of levetiracetam in partial seizures.
    Devinsky O; Elger C
    Epileptic Disord; 2003 May; 5 Suppl 1():S27-31. PubMed ID: 12915338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.